News & Updates

Show Multimedia Only
Gout, hyperuricaemia meds less common among diabetics on SGLT2is

Gout, hyperuricaemia meds less common among diabetics on SGLT2is

28 Aug 2022

Patients with type 2 diabetes mellitus (T2DM) taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) are less likely to be prescribed antigout or antihyperuricaemic drugs, a recent study has found.

Gout, hyperuricaemia meds less common among diabetics on SGLT2is

28 Aug 2022
FMT plus anti-inflammatory diet induces, preserves remission in UC

FMT plus anti-inflammatory diet induces, preserves remission in UC

28 Aug 2022

Patients with mild-to-moderate ulcerative colitis (UC) can achieve deep remission with multidonor faecal microbiota transplantation (FMT) and anti-inflammatory diet, according to an open-label trial. Furthermore, remission can be sustained with anti-inflammatory diet over 1 year.

FMT plus anti-inflammatory diet induces, preserves remission in UC

28 Aug 2022
Dulaglutide safely controls glucose in T2D with CKD

Dulaglutide safely controls glucose in T2D with CKD

28 Aug 2022

In patients with type 2 diabetes (T2D) with chronic kidney disease (CKD), once-weekly dosage with dulaglutide achieves adequate glycaemic control along with a reduced decline in estimated glomerular filtration rate (eGFR), reports a recent study.

Dulaglutide safely controls glucose in T2D with CKD

28 Aug 2022
Minor physical anomalies more common in epilepsy

Minor physical anomalies more common in epilepsy

27 Aug 2022

Patients with epilepsy more commonly have minor physical anomalies (MPA), suggesting a neurodevelopmental dimension to epilepsy, a recent study has found.

Minor physical anomalies more common in epilepsy

27 Aug 2022
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO

Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO

27 Aug 2022